UBS Maintains a 'Buy' on McKesson (MCK); Q4 Earnings Preview
Tweet
Share
E-mailGet Alerts MCK Hot Sheet
Price: $858.90 --0%
Rating Summary:
21 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 53
Rating Summary:
21 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 53
Join SI Premium – FREE
UBS maintains a 'Buy' on McKesson (NYSE: MCK), raises PT from $89 to $95.
UBS analyst says, "MCK is expected to report F4Q11 EPS after the close on Tuesday. Our $1.60 EPS estimate is in line with consensus. While there is potential for drug distribution upside, the HCIT segment is the more difficult segment to predict, in our view (we project 55% EBIT growth). This is due to the large ramp in EBIT suggested by mgmt, offset by commentary at the HIMSS conference about salesforce layoffs."
"We are projecting ‘distribution solutions’ EBIT of $649 mil, or 15% growth y-o-y when adjusting for M&A and flu. This is slightly below the 17% and 18% organic distribution EBIT growth reported last week by AmerisourceBergen (NYSE: ABC) and Cardinal Health (NYSE: CAH), respectively. So we see room for upside relative to peers in the MCK distribution operations."
For more ratings news on McKesson click here and for the rating history of McKesson click here.
Shares of McKesson closed at $84.21 yesterday.
UBS analyst says, "MCK is expected to report F4Q11 EPS after the close on Tuesday. Our $1.60 EPS estimate is in line with consensus. While there is potential for drug distribution upside, the HCIT segment is the more difficult segment to predict, in our view (we project 55% EBIT growth). This is due to the large ramp in EBIT suggested by mgmt, offset by commentary at the HIMSS conference about salesforce layoffs."
"We are projecting ‘distribution solutions’ EBIT of $649 mil, or 15% growth y-o-y when adjusting for M&A and flu. This is slightly below the 17% and 18% organic distribution EBIT growth reported last week by AmerisourceBergen (NYSE: ABC) and Cardinal Health (NYSE: CAH), respectively. So we see room for upside relative to peers in the MCK distribution operations."
For more ratings news on McKesson click here and for the rating history of McKesson click here.
Shares of McKesson closed at $84.21 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocMorris AG (DOCM:SW) PT Raised to CHF12.50 at Deutsche Bank
- Morgan Stanley Downgrades PWR Holdings Ltd. (PWH:AU) to Equalweight
- JPMorgan Upgrades Diploma Plc. (DPLM:LN) to Overweight
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
UBS, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
